Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -342 | -226 | -140 | N/A | -437 |
| Depreciation Amortization | 0 | 0 | 0 | N/A | 8 |
| Accounts payable and accrued liabilities | -19 | -22 | 34 | N/A | -110 |
| Other Working Capital | 21 | -11 | 25 | N/A | -57 |
| Other Operating Activity | 19 | 22 | -34 | 0 | 112 |
| Operating Cash Flow | $-321 | $-236 | $-114 | $N/A | $-484 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18 | 37 | -6 | N/A | 32 |
| PPE Investments | -1 | -1 | N/A | N/A | N/A |
| Investing Cash Flow | $16 | $36 | $-6 | $N/A | $32 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 500 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $500 |
| Beginning Cash Position | 4,769 | 4,769 | 4,769 | N/A | 69 |
| End Cash Position | 4,464 | 4,568 | 4,649 | N/A | 116 |
| Net Cash Flow | $-305 | $-200 | $-120 | $N/A | $47 |
| Free Cash Flow | |||||
| Operating Cash Flow | -321 | -236 | -114 | N/A | -484 |
| Capital Expenditure | -1 | -1 | N/A | N/A | N/A |
| Free Cash Flow | -322 | -237 | -114 | 0 | -484 |